Prostate SBRT Dose Escalation (9 Gy  × 5, 13.3 Gy × 3, 24 Gy × 1): Are We Making Progress?

Recently, 3 prospective clinical trials have evaluated dose-escalated stereotactic body radiation therapy (SBRT) in localized prostate cancer, 2 of which have appeared in the Red Journal.1-3 We commend all of the authors for the conduct of these clinical trials, and each of these groups has attempted to push the envelope further in the delivery of prostate SBRT.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Editorial Source Type: research